Insider · CIK 0001973027
Remy Durand
Files at ALPN (ALPINE IMMUNE SCIENCES, INC.). First filing -, latest -.
In brief
Remy Durand files SEC Form 4 as officer at ALPN (ALPINE IMMUNE SCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Remy Durand has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -102,192 | - | - | 31,200 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -31,200 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -2,635 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -26,922 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -70,155 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -112,500 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -109,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -78,000 | - | - | 0 | May 20, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +9,845 | $13.20 | $130k | 47,949 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +25,000 | $6.51 | $163k | 72,949 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +12,365 | $4.09 | $51k | 85,314 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +38,078 | $3.23 | $123k | 123,392 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +10,000 | $4.76 | $48k | 133,392 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -9,845 | $0.00 | $0 | 70,155 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -25,000 | $0.00 | $0 | 0 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -12,365 | $0.00 | $0 | 2,635 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -38,078 | $0.00 | $0 | 26,922 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -10,000 | $0.00 | $0 | 0 | May 10, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Common Stock | +31,200 | $0.00 | $0 | 38,104 | Jan 5, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Stock Option (Right to buy)derivative | +78,000 | $0.00 | $0 | 78,000 | Jan 5, 2024 |
Questions about Remy Durand
Answered from the filings on this page, as of the latest one.
Is Remy Durand buying or selling?
Remy Durand has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Remy Durand's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Remy Durand has 0.
Where does Remy Durand file Form 4?
Remy Durand has filed Form 4 at ALPN (ALPINE IMMUNE SCIENCES, INC.) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.